Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study
In this study, we evaluated the efficacy and toxicity of stereotactic body radiotherapy (SBRT) as replacement strategy of conventionally fractionated radiation therapy in stage III non-small cell lung cancer (...
Source: Radiation Oncology - Category: Cancer & Oncology Authors: Zhen Jia, Fang Fang, Yangsen Cao, Xiaofei Zhu, XiaoYu Yang, Xueling Guo and Huojun Zhang Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Study | Toxicology